Patients’ Perspectives Regarding Ankylosing Spondylitis Treatment Administration Features: Evidence from Qualitative Interviews and a Multinational Quantitative Preference Survey
Treatment preferences differed depending on whether AT was currently used and disease was well controlled. Findings enhance understanding of which patients may prefer different modes of AT administration.
Authors
- Kathleen Marie Beusterien (ORCID: https://orcid.org/0000-0001-7786-5422)
- Lawrence Rick Phillips
- Martine C. Maculaitis (ORCID: https://orcid.org/0000-0001-8388-5315)
- Lewis Kopenhafer
- You‐Li Ling
- Arne Yndestad
- Atul Deodhar
- Mostafa Zayed
- Joseph C. Cappelleri
- Brett Hauber
Institutions
- Oracle (United States) (US)
- Oregon Health & Science University (US)
- Pfizer (United States) (US)
- National Patient Safety Foundation (US)
Publication Details
- Journal
- Rheumatology and Therapy
- Published
- 2026-01-20
- DOI
- https://doi.org/10.1007/s40744-025-00824-z
- Primary Topic
- Spondyloarthritis Studies and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer